Johnson & Johnson Files 8-K with Financial Updates

Ticker: JNJ · Form: 8-K · Filed: Oct 15, 2024 · CIK: 200406

Johnson & Johnson 8-K Filing Summary
FieldDetail
CompanyJohnson & Johnson (JNJ)
Form Type8-K
Filed DateOct 15, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$1.00
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, debt, sec-filing

Related Tickers: JNJ

TL;DR

JNJ filed an 8-K on Oct 15, 2024, showing debt maturities and financial details.

AI Summary

On October 15, 2024, Johnson & Johnson filed an 8-K report detailing financial information. The filing includes details on various notes due in different years, such as A5.50 Notes Due 2024 and A1.150 Notes Due November 2028, indicating ongoing financial operations and debt management.

Why It Matters

This filing provides investors with current information on Johnson & Johnson's financial condition, including details on its outstanding debt obligations.

Risk Assessment

Risk Level: low — This is a routine financial filing with no immediate negative or positive news, making the risk level low.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Johnson & Johnson?

The primary purpose is to report on the Results of Operations and Financial Condition, as well as to file Financial Statements and Exhibits.

What specific debt instruments are mentioned in the filing?

The filing mentions A5.50 Notes Due 2024, A1.150 Notes Due November 2028, A3.20 Notes Due November 2032, A1.650 Notes Due 2035, A3.350 Notes Due November 2036, and A3.550 Notes Due November 2044.

On what date was this 8-K report filed?

The report was filed on October 15, 2024.

What is Johnson & Johnson's state of incorporation and fiscal year end?

Johnson & Johnson is incorporated in New Jersey and its fiscal year ends on December 29.

What is the SIC code for Johnson & Johnson?

The Standard Industrial Classification (SIC) code for Johnson & Johnson is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 502 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-10-15 07:37:20

Key Financial Figures

Filing Documents

02 Results of operations and financial condition

Item 2.02 Results of operations and financial condition On October 15, 2024, Johnson & Johnson issued the attached press release (Exhibit 99.1) announcing its sales and earnings for the third quarter ended September 29, 2024.

01 Financial statements and exhibits

Item 9.01 Financial statements and exhibits (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Press Release dated October 15 , 2024 for the period ended September 29 , 2024 99.2 Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings for the fiscal third quarter and nine months 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

Signatures

Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 15, 2024 JOHNSON & JOHNSON (Registrant) By: /s/ Robert J. Decker, Jr. Robert J. Decker, Jr. Controller (Principal Accounting Officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing